SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
GlobeNewswire
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage..
Duke University School of Medicine
News and Video Search Results
News coverage
-
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
GlobeNewswire
-
Buildings across the nation to light up green for Mental Health Month in May
GlobeNewswire
-
Nexstim Plc Business Update Q1 2024
GlobeNewswire
-
Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation
GlobeNewswire
0 shares
1 views
You might like
Duke University School of Medicine media coverage
The Joint Commission Enterprise Announces Four Appointments to Executive Leadership Team
GlobeNewswire
OAKBROOK TERRACE, Illinois, April 11, 2024 (GLOBE NEWSWIRE) -- (OAKBROOK TERRACE, Illinois, April 11, 2024) – Building on a..
-
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
GlobeNewswire
-
Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer
GlobeNewswire
-
Celebrating Child Life Month
Accesswire
-
Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards
GlobeNewswire
Advertisement
More coverage
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
GlobeNewswire
· PEMGARDA (pemivibart) is authorized in the U.S. for PrEP of COVID-19 in certain adults and adolescents with moderate-to-severe..
-
Biotechnology Industry Insights: Comprehensive Report on Collaboration Deals from 2019-2024 Now Available
GlobeNewswire
-
Pharmaceutical and Biotechnology Sector Insights: Comprehensive Analysis of Option and Evaluation Deals (2016-2024)
GlobeNewswire
-
Ocugen Clinical Showcase Webcast Now Available
GlobeNewswire
-
Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
GlobeNewswire